您的位置: 首页 > 农业专利 > 详情页

Crystalline(2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-YL)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
专利权人:
LLC;Theravance Biopharma R&D IP
发明人:
Baldwin, R. Michael,Bourdet, David L.,Hughes, Adam D.,Fleury, Melissa,Rapta, Miroslav,Thalladi, Venkat R.,Fass, Gene Timothy,Simeone, Michael
申请号:
AU2017229466
公开号:
AU2017229466A1
申请日:
2017.03.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
In one aspect, the invention relates to a crystalline form of the structure: or a pharmaceutically acceptable salt thereof, having neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising this crystalline form; methods of using this crystalline form and its soluble form (I); and processes for preparing soluble (I) and crystalline (I') forms.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充